Zhao, Lei
Li, Zhongqi http://orcid.org/0000-0003-2554-9334
Vong, Joaquim S. L.
Chen, Xinyi
Lai, Hei-Ming
Yan, Leo Y. C.
Huang, Junzhe
Sy, Samuel K. H.
Tian, Xiaoyu http://orcid.org/0000-0003-3472-9898
Huang, Yu http://orcid.org/0000-0002-1277-6784
Chan, Ho Yin Edwin
So, Hon-Cheong
Ng, Wai-Lung http://orcid.org/0000-0003-2892-6318
Tang, Yamei
Lin, Wei-Jye
Mok, Vincent C. T.
Article History
Received: 1 November 2019
Accepted: 12 August 2020
First Online: 4 September 2020
Competing interests
: Exenatide used in the study was provided by AstraZeneca Hong Kong Limited. L.Y.C.Y. and J.H. were employed by Aptorum Group Limited and honorary research staff of CUHK. AstraZeneca Hong Kong Limited and Aptorum Group Limited had otherwise no role in the funding, design, or execution of the study.